Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- RFA-OD-20-018
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance
- 93.233 National Center on Sleep Disorders Research
- 93.279 Drug Use and Addiction Research Programs
- 93.310 Trans-NIH Research Support
- 93.350 National Center for Advancing Translational Sciences
- 93.394 Cancer Detection and Diagnosis Research
- 93.837 Cardiovascular Diseases Research
- 93.838 Lung Diseases Research
- 93.839 Blood Diseases and Resources Research
- 93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- Funding instrument
- Cooperative Agreement
- Categories
-
- Education
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- State Governments
- 501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- Special District Governments
- Independent School Districts
- Other
- For Profit Organizations
- Small Businesses
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- County Governments
- City/Township Governments
- Tribal Organizations (Not Federally Recognized)
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
In response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS) for the 2019 Novel Coronavirus (COVID-19), the National Institutes of Health (NIH) has launched the Rapid Acceleration of Diagnostics (RADx) project. This emergency funding opportunity announcement (FOA) from NIH provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative for the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other markers of the COVID-19 disease that can be used in future outbreaks of COVID-19 and that could be applicable to other, as yet unknown, viruses. Specifically, this FOA seeks to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for the detection of SARS-CoV-2. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. NIH requires that all projects funded under this FOA will actively coordinate, collaborate, and share data with the RADx-rad Data Coordinating Center, as allowed, and with considerations under tribal IRB processes, as appropriate. Researchers applying to this funding opportunity are strongly encouraged to review the companion Data Coordinating Center (DCC) funding opportunity announcement.
Files
| File | Type | Posted |
|---|---|---|
| PKG00262919-instructions.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity